Fetveit A, Bjorvatn B Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home patients with dementia: a pilot study. Am J Geriatr Psychiatry. 2005 May;13(5):420-3. doi: 10.1176/appi.ajgp.13.5.420.
Karlsen KH, Tandberg E, Arsland D, Larsen JP Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):584-9. doi: 10.1136/jnnp.69.5.584.
Klerman EB, Duffy JF, Dijk DJ, Czeisler CA Circadian phase resetting in older people by ocular bright light exposure. J Investig Med. 2001 Jan;49(1):30-40. doi: 10.2310/6650.2001.34088.
Mishima K, Okawa M, Shimizu T, Hishikawa Y Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metab. 2001 Jan;86(1):129-34. doi: 10.1210/jcem.86.1.7097.
Moore RY, Eichler VB Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 1972 Jul 13;42(1):201-6. doi: 10.1016/0006-8993(72)90054-6. No abstract available.
Moore-Ede MC, Czeisler CA, Richardson GS Circadian timekeeping in health and disease. Part 2. Clinical implications of circadian rhythmicity. N Engl J Med. 1983 Sep 1;309(9):530-6. doi: 10.1056/NEJM198309013090905. No abstract available.
Myers BL, Badia P Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev. 1995 Winter;19(4):553-71. doi: 10.1016/0149-7634(95)00018-6. Erratum In: Neurosci Biobehav Rev 1996 Summer;20(2):I-IV.
Phipps-Nelson J, Redman JR, Dijk DJ, Rajaratnam SM Daytime exposure to bright light, as compared to dim light, decreases sleepiness and improves psychomotor vigilance performance. Sleep. 2003 Sep;26(6):695-700. doi: 10.1093/sleep/26.6.695.
Schindler SD, Graf A, Fischer P, Tolk A, Kasper S Paranoid delusions and hallucinations and bright light therapy in Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Nov;17(11):1071-2. doi: 10.1002/gps.497.
Shochat T, Martin J, Marler M, Ancoli-Israel S Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res. 2000 Dec;9(4):373-9. doi: 10.1046/j.1365-2869.2000.00221.x.
Tandberg E, Larsen JP, Karlsen K A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord. 1998 Nov;13(6):895-9. doi: 10.1002/mds.870130606.
Van Someren EJ, Riemersma RF, Swaab DF Functional plasticity of the circadian timing system in old age: light exposure. Prog Brain Res. 2002;138:205-31. doi: 10.1016/S0079-6123(02)38080-4. No abstract available.
Wever RA, Polasek J, Wildgruber CM Bright light affects human circadian rhythms. Pflugers Arch. 1983 Jan;396(1):85-7. doi: 10.1007/BF00584704.
Effects of Bright Light Treatment on Daytime Sleepiness and Nocturnal Sleep in Patients With Parkinson's Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.